Digenic Junctional Epidermolysis Bullosa: Mutations in COL17A1 and LAMB3 Genes  by Floeth, Michaela & Bruckner-Tuderman, Leena
Am. J. Hum. Genet. 65:1530–1537, 1999
1530
Digenic Junctional Epidermolysis Bullosa: Mutations in COL17A1 and
LAMB3 Genes
Michaela Floeth and Leena Bruckner-Tuderman
Department of Dermatology, University of Mu¨nster, Mu¨nster
Summary
Junctional epidermolysis bullosa (JEB), a genetically
heterogeneous group of blistering skin diseases, can
be caused by mutations in the genes encoding laminin
5 or collagen XVII, which are components of the hem-
idesmosome-anchoring filament complex in the skin.
Here, a family with severe nonlethal JEB and with
mutations in genes for both proteins was identified.
The index patient was compound heterozygous for
the COL17A1 mutations L855X and R1226X and
was heterozygous for the LAMB3 mutation R635X.
As a consequence, two functionally related proteins
were affected. Absence of collagen XVII and attenu-
ated laminin 5 expression resulted in rudimentary
hemidesmosome structure and separation of the epi-
dermis from the basement membrane, with severe skin
blistering as the clinical manifestation. In contrast,
single heterozygotes carrying either (1) one or the
other of the COL17A1 null alleles or (2) a double
heterozygote for a COL17A1 and a LAMB3 null allele
did not have a pathological skin phenotype. These
observations indicate that the known allelic hetero-
geneity in JEB is further complicated by interactions
between unlinked mutations. They also demonstrate
that identification of one mutation in one gene is not
sufficient for determination of the genetic basis of JEB
in a given family.
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Introduction
Junctional epidermolysis bullosa (JEB) refers to a het-
erogeneous group of recessively inherited disorders
with skin fragility, ultrastructurally abnormal hemi-
desmosomes (McMillan et al. 1998), and separation
of the epidermis from the basement membrane. JEB
includes several subtypes, varying from lethal JEB
Herlitz (MIM 226700) to mild acral affection (Gedde-
Dahl and Anton-Lamprecht 1996; Bruckner-Tuder-
man, in press), that are caused by mutations in at least
six different genes encoding components of the hemi-
desmosome-anchoring filament complex in the skin,
laminin 5, a6b4 integrin, and collagen XVII (Pulk-
kinen and Uitto 1999).
JEB Herlitz is a severe condition that results
in premature demise of the affected individuals with-
in a few months of birth. Mutations in the three
genes—LAMA3, LAMB3, and LAMC2—encoding
the a3, b3, and g2 polypeptide subunits of laminin
5 underlie this subtype (Pulkkinen and Uitto 1999).
Characteristically, premature termination codons in
both alleles of any of these three genes signify poor
prognosis as a result of absence of laminin 5 in the
skin of the affected individuals. In contrast, rare mis-
sense mutations in one or both alleles are associated
with relatively mild phenotypes (McGrath et al.
1996a).
Generalized atrophic benign epidermolysis bullosa
(GABEB [MIM 226650]) represents a nonlethal subtype
with blistering, skin atrophy, alopecia, nail dystrophy,
and dental anomalies. COL17A1 gene mutations un-
derlie the majority of GABEB cases (McGrath et al.
1995, 1996b, 1996c; Chavanas et al. 1997; Gatalica et
al. 1997; Jonkman et al. 1997; Schumann et al. 1997;
Floeth et al. 1998; Darling et al. 1999). Most of these
are homozygous or heterozygous mutations leading to
a premature-termination codon and absence of collagen
XVII in the skin, whereas missense mutations in one or
both alleles are associated mainly with acral blistering
and mild skin atrophy (Schumann et al. 1997).
Laminin 5 and collagen XVII are components of
the hemidesmosome-anchoring filament complex at
the dermal/epidermal junction (Rousselle et al. 1997;
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Figure 1 Phenotype of the proband. The clinical phenotype in-
cluded features of both the GABEB and JEB Herlitz subtypes. A, Pro-
band seen, at the age of 7 mo, with generalized skin blistering but
with minimal involvement of the mucous membranes and with normal
body height and weight. B, Paronychia-like affection of the fingers, as
typically seen in JEB Herlitz.
Scha¨cke et al. 1998). This complex is pivotal for a
stable association between the epidermis and the un-
derlying dermis. It consists of (1) hemidesmosomes
that extend from the intracellular space of basal ker-
atinocytes to the basement membrane zone and (2)
anchoring filaments—threadlike structures that ex-
tend from the hemidesmosomes to the underlying lam-
ina densa of the basement membrane. Hemidesmo-
somes contain at least four proteins that display
defined interactions with each other, as well as with
other components of the basement membrane. These
are the cytoskeleton-associated proteins BP230 and
plectin and the transmembrane components collagen
XVII and a6b4 integrin (Nievers et al. 1999). The
anchoring filaments contain laminin 5, a member of
the laminin family of proteins, which consists of the
a3, b3, and g2 chains encoded by distinct genes
LAMA3, LAMB3, and LAMC2 (Aumailley and Rous-
selle 1999). The extracellular domain of collagen XVII
is likely to contribute to the structure of the anchoring
filaments, since it colocalizes with laminin 5 (Masun-
aga et al. 1997) and binds to it in vitro (Reddy et al.
1998).
Here we describe a family with JEB that has abnormal
expression of two functionally related proteins, collagen
XVII and laminin 5, that is caused by mutations in two
unlinked genes. The absence of collagen XVII and the
reduction in the amount of laminin 5 in the skin lead
to a severe blistering phenotype with features of both
the lethal Herlitz and the nonlethal GABEB subtypes.
Material and Methods
Clinical and Diagnostic Features
The male proband, who is now 2 years old, is a prod-
uct of a nonconsanguineous union. The parents and two
half-sisters were unaffected, and there was no family
history of skin or genetic diseases. The proband was
born with acral skin blistering and with large erosions
of the feet and shins. Within days, the fingertips were
affected in a paronychia-like fashion, the mucous mem-
branes were involved, and the pressure-prone areas in
the back and buttocks were severely affected. Diagnostic
electron microscopy of a postnatal skin-biopsy specimen
revealed separation of the epidermis from the dermis,
along the lamina lucida of the basement membrane and
rudimentary hemidesmosomes. JEB Herlitz was sus-
pected, and a subsequent mutation screening (T. Gedde-
Dahl Jr., personal communication) revealed the presence
of the heterozygous LAMB3 mutation R635X (Kivi-
rikko et al. 1996). Lethal JEB Herlitz was diagnosed.
However, at the age of 7 mo, the proband had normal
body weight and height, generalized skin blistering with
emphasis in acral areas (fig. 1), mild affection of oral
mucosa, and no involvement of internal organs. In the
course of the disease, the symptoms remained stable,
with the blistering being more severe at trauma-exposed
and pressure-prone areas. The lesions resolved without
scarring but with a mild skin atrophy, possibly as a con-
sequence of secondary inflammatory processes. Dystro-
phy of all nails developed, whereas mucous membranes
remained mildly affected. The teeth were dystrophic. A
slight frontal alopecia was noted at the age of 18 mo.
On examination of the family members, no skin blis-
tering or nail dystrophy was observed, but the mother
and both half-sisters presented with dental anoma-
lies—that is, enamel hypoplasia and pitting.
Skin-biopsy specimens were obtained from the index
patient and from both parents, and blood samples for
mutation analysis were obtained from affected and un-
affected family members. This study was approved by
the institutional review board for human studies at the
University of Mu¨nster, and informed consent was ob-
tained from the family members before the tissue and
blood samples were taken.
Mutation Detection
Genomic DNA was isolated from peripheral blood
by use of the QIAAmp Blood Kit (QIAGEN), accord-
ing to the manufacturer’s instructions. PCR amplifi-
cation of COL17A1 exons 37 and 51 was performed
as described elsewhere (Gatalica et al. 1997; see also
GenBank). The primers used for amplification of
COL17A1 exon 37 were as follows: sense primer 5′-
AGAGGTGAGAAGTGTGGCAG-3′ and antisense
primer 5′-GCAGAAGAGAGCAAGGAAGA-3′. The
size of the PCR product was 261 bp. Primers used for
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amplification of COL17A1 exon 51 were as follows:
sense primer 5′-TTTCTCTCCTCCCATCACCC-3′
and antisense primer 5′-TGTCCCTTTAAGTGCCT
CCC-3′. The size of the PCR product was 374 bp.
Heteroduplex analysis was performed as described by
Ganguly et al. (1993), and heteroduplex-forming PCR
products were sequenced by an automated sequencer
(Genome Express). The mutation screening in LAMB3
exon 14 was performed as described elsewhere (Ki-
virikko et al. 1996). The primers used for amplifica-
tion of the LAMB3 exon 14 were as follows: sense
primer 5′-GCTGCGACTTCTGTTATTCT-3′ and an-
tisense primer 5′-AAATGTAAGGAAGGACCAGC-3′.
The size of the amplification product was 578 bp. The
mutation was verified by both BglII digestion and di-
deoxynucleotide sequencing.
Northern Blotting
mRNA was isolated from cultured JEB and control
keratinocytes, with the use of the Oligotex Direct
mRNA Minikit (QIAGEN). For northern blotting, 1.5
mg mRNA was separated on formaldehyde-containing
agarose gels and was then capillary transferred onto
a positively charged nylon membrane. For hybridi-
zation, two probes were used—a collagen XVII cDNA
(Floeth et al. 1998) and a LAMB3 amplification prod-
uct—which were labeled by use of the digoxigenin
DNA Labeling Kit (Roche Diagnostics). Detection was
with alkaline phosphatase–labeled digoxigenin anti-
bodies and with chlordioxetan phenyl phosphate
CDP-Star chemiluminiscence substrate (Roche Diag-
nostics). Densitometric analysis of the bands was
quantitated with the use of the BIO PROFIL software
program (Vilber Lourmat France 96).
Immunodetection of Proteins
Indirect immunofluorescence staining of skin cryosec-
tions was performed by standard techniques and with
the following primary antibodies: monoclonal antibod-
ies 1A8C to the intracellular domain of collagen XVII
and 1D1 to the extracellular domain of collagen XVII
(generously provided by Dr. K. Owaribe, School of In-
formatics and Sciences, Nagoya, Japan), cytokeratins
(Dako), BP230 (a high-titer autoantiserum from a pem-
phigoid patient), a6 and b4 integrins (Gibco Life Tech-
nologies), collagen IV (Dako), chain-specific antibodies
to laminin 5 (a3- and b2-chain antibodies BM-165 and
6F12, respectively, which were kind gifts of Dr. R. Burge-
son, Cutaneous Biology Research Center, Harvard Med-
ical School, Cambridge, MA), g2-chain antibody GB3
(kindly provided by Dr. J.-P. Ortonne, University of Nice,
France), and collagen VII (Bruckner-Tuderman et al.
1995).
Results
Identification and Verification of Mutations
Since the proband’s phenotype had features of both
the JEB-Herlitz and GABEB subtypes, mutations in both
LAMB3 and COL17A1 were analyzed. The LAMB3
mutation R635X was traced by PCR amplification of
exon 14, followed by BglII digestion of the PCR prod-
ucts (Kivirikko et al. 1996). Dideoxynucleotide sequenc-
ing revealed, at nucleotide position 1903 of the LAMB3
cDNA, a CrT transition that caused a premature-ter-
mination codon. Verification by BglII digestion showed
also that the mother was heterozygous for this mutation
(fig. 2).
COL17A1 mutation screening included PCR am-
plification of genomic DNA and heteroduplex analysis
of the PCR products (Gatalica et al. 1997). Broadened
bands of exons 37 and 51 in conformation-sensitive
gel electrophoresis suggested heteroduplex formation
and, therefore, heterozygosity. Dideoxynucleotide se-
quencing showed that the index patient was hetero-
zygous for a 2669TrG transversion in exon 37, a
novel nonsense mutation designated “L855X” (fig. 2).
Verification with AspI digestion demonstrated that his
father and paternal grandmother were heterozygous
for this mutation. The proband was also heterozygous
for a 3781CrT transition in exon 51, which was des-
ignated “R1226X” (McGrath et al. 1995; Jonkman
et al. 1997; Schumann et al. 1997). Verification with
TaqI digestion demonstrated that his mother and both
half-sisters were heterozygous for this mutation. Both
COL17A1 mutations caused a premature-termination
codon and were not found in 150 chromosomes of
asymptomatic unrelated individuals. The presence of
the LAMB3 mutation R635X was investigated, by
BglII digestion, in the genomic DNA of 16 unrelated
patients with either GABEB or localized JEB and in
that of 26 asymptomatic COL17A1 mutation carriers;
however, it was not found in any of the samples.
Expression of COL17A1 and LAMB3 mRNA
Northern blots with normal keratinocyte mRNA
showed a strong 6-kb collagen XVII mRNA signal (fig.
3). In contrast, mRNA from the patient’s keratinocytes
produced no signal, suggesting nonsense-mediated
mRNA decay in these cells (Hentze and Kulozik 1999).
Hybridization of the normal mRNA with a LAMB3
cDNA probe showed a strong 3.5-kb laminin 5 b3 sig-
nal, but mRNA from the patient’s keratinocytes pro-
duced a clearly weaker band (fig. 3). Densitometric
scanning of the LAMB3 bands, in relation to the glyc-
eraldehyde-phosphate-dehydrogenase signals, indica-
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Figure 2 Pedigree and LAMB3 and COL17A1 mutations. A, Pedigree demonstrating recessive inheritance of the mutations. Areas with
horizontal stripes indicate paternal COL17A1 mutations; dotted areas, maternal COL17A1 mutations; blackened areas, maternal LAMB3
mutations. B, Paternal COL17A1 mutation, which was novel—a heterozygous 2669 TrG transversion in exon 37—and was designated “L855X.”
Verification of the mutation by AspI digestion demonstrated that the father and the paternal grandmother were heterozygous for this mutation.
C, Maternal COL17A1 mutation, which was a heterozygous 3781CrT transition in exon 51 and was designated “R1226X” (McGrath et al.
1995; Jonkman et al. 1997; Schumann et al. 1997). The mutation was also found, by TaqI digestion, in the mother’s and both the half-sisters’
DNA, but it was not found in a control or in the father. D, LAMB3 mutation R635X (Kivirikko et al. 1996), which was verified by both BglII
digestion of the PCR amplification products of exon 14 and by dideoxynucleotide sequencing (not shown). In addition to the proband, the
mother was heterozygous for this mutation. In B–D, the numbers above the agarose-gel images denote the individuals in the pedigree, and “C”
denotes the control.
ted that the JEB cells contained 55% of the LAMB3
mRNA of control keratinocytes.
Collagen XVII and Laminin 5 Protein in the Skin
Indirect immunofluorescence staining with collagen
XVII and laminin 5 antibodies showed a linear signal
along the basement-membrane zone of normal skin
(fig. 4A and B). In the skin of the patient, staining
with different domain-specific collagen XVII antibod-
ies was negative (fig. 4C), whereas staining with chain-
specific antibodies to the laminin 5 a3, b3, and g2
chains showed a positive fluorescent signal—but
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Figure 3 Northern blotting of collagen XVII and laminin 5
mRNA. A strong signal of the 6-kb collagen XVII mRNA was detected
in control keratinocytes (left panel). In contrast, collagen XVII mRNA
that was isolated from the JEB patient’s keratinocytes (left panel) pro-
duced a negative signal, suggesting nonsense-mediated mRNA decay
in these cells. The blot was intentionally overexposed to reveal po-
tentially small amounts of mRNA in the patient’s cells. When laminin
5 cDNA was used for hybridization, a strong 3.5-kb laminin 5 mRNA
band was seen in normal keratinocytes (right panel). The keratinocytes
of the patient with JEB produced a clearly weaker band (right panel).
GAPDH cDNA was used as a reference probe to correct for minor
differences in RNA loading. Densitometric analysis of the laminin 5
signals indicated that the patient’s cells contained ∼55% of the laminin
5 mRNA seen in controls. C = control; Pat = patient.
Figure 4 Collagen XVII and laminin 5 protein expression in
situ. Indirect immunofluorescence staining of control (A and B) and
JEB (C and D) skin biopsy specimens, with antibodies to collagen
XVII (A and C) and laminin 5 (B and D). In normal skin, both collagen
XVII (A) and laminin 5 (B) antibodies showed a linear fluorescence
at the dermal-epidermal junction. In the proband’s skin, collagen XVII
was absent (C ), and the laminin 5 staining was attenuated (D).
weaker than that seen in controls (fig. 4D). This find-
ing, together with the northern blot signals, suggested
that the JEB skin contained lower amounts of laminin
5 than did the control skin and that the synthesis of
the b3 chain was not compensatorily up-regulated. In
spontaneously blistered skin of the proband, antibod-
ies to cytokeratins, BP230, and a6 and b4 integrins
bound to the blister roof, and the antibodies to col-
lagens IV and VII bound to the blister floor. This stain-
ing pattern was congruent with junctional-tissue sep-
aration (Hintner et al. 1981). Immunofluorescence
staining patterns of the parents’ skin samples were
indistinguishable from those of controls.
Discussion
Digenic mutations have been reported in a few human
diseases, such as retinitis pigmentosa (Kajiwara et al.
1994; Dryja et al. 1997), nonsyndromic hereditary hear-
ing loss (Balciuniene et al 1998), and Waardenburg syn-
drome type 2 and autosomal recessive ocular albinism
(Morell et al. 1997). The most extensively studied di-
genic disease is retinitis pigmentosa caused by mutations
in the unlinked genes ROM1, on chromosomal locus
11q, and periferin/RDS, on locus 6p, both of which en-
code the polypeptide subunits of a photoreceptor protein
complex. In Waardenburg syndrome type 2 in conjunc-
tion with ocular albinism, the phenotype has been sug-
gested to result from digenic interactions between a gene
for the transcription factor microphthalmia-associated
transcription factor and a gene, TYR, that it regulates
and that encodes tyrosinase (Morell et al. 1997).
We identified digenic mutations in two unlinked genes,
LAMB3 and COL17A1, in subjects with JEB. The for-
mer gene is localized on chromosomal locus 1q32, the
latter on 10q24.3. Homozygous or compound-hetero-
zygous mutations in either gene have been known to be
associated with JEB (Pulkkinen and Uitto 1999), but the
present observations demonstrate that digenic interac-
tions can cause additional heterogeneity. Similar to the
ROM1 and the periferin/RDS gene products, which are
polypeptide components of a transmembrane-protein
complex in the retinal photoreceptors, the affected mol-
ecules in JEB are structural proteins of the hemides-
mosome-anchoring filament complex, an oligomeric
transmembrane-protein complex in the epidermis. Like
rom-1 and periferin/rds, laminin 5 and collagen XVII
have been postulated to be functionally related (Reddy
et al. 1998), and our recent data indeed demonstrate
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that these two trimeric proteins interact noncovalently
in vitro (M. Aumailley, K. Tasanen, and L. Bruckner-
Tuderman, unpublished observation). In the absence of
collagen XVII from the skin, half-normal amounts of
laminin 5 seem insufficient for formation of functional
hemidesmosome-anchoring filament complexes. In anal-
ogy, the periferin/RDS mutant L185P cannot form na-
tivelike homotetramers on its own (Goldberg and Mol-
day 1996), but it can assemble with wild-type rom-1 to
form structurally normal heterotetramers. However, if
rom-1 is also defective, a pathological phenotype results.
The mutation R635X is one of two known recurrent
LAMB3 mutations in JEB Herlitz; the other is R42X
(Kivirikko et al. 1996). Identification of these two pre-
dominant gene defects has led to a mutation-detection
strategy for JEB Herlitz that first analyzes, by restriction-
enzyme digestions, the LAMB3 gene for these two com-
mon mutations and that then, if the results are negative,
continues with heteroduplex scanning of the other
LAMB3 exons and, finally, of the other laminin 5–en-
coding genes (Pulkkinen et al. 1997). This procedure was
also followed in the case of the present proband with
clinical and ultrastructural features suggestive of JEB
Herlitz. The disclosure of the heterozygous R635X mu-
tation endorsed the initial diagnosis of JEB Herlitz and
led to counseling of the parents about poor prognosis
and early demise of the proband. However, the course
of the disease—that is, normal growth and lack of in-
volvement of internal organs at the age of 7 mo—were
not typical of JEB Herlitz. Subsequent antigen mapping
of the skin basement-membrane zone revealed the ab-
sence of collagen XVII, thus identifying a second can-
didate gene.
Mutation screening of COL17A1 disclosed compound
heterozygosity for nonsense mutations in this gene. Such
genetic constellations are known in GABEB, but the clin-
ical phenotype of the present proband was more exten-
sive, showing features of both GABEB and JEB Herlitz.
In general, GABEB phenotypes caused by COL17A1
mutations are milder and lack paronychia-like affection
of the fingers and toes and severe affection of the but-
tocks. It seems that the severe phenotype and the JEB
Herlitz–like features of the present proband resulted
from digenic interactions. Biologically, lack of collagen
XVII leads to weakened hemidesmosome-cytoskeleton
and hemidesmosome-anchoring filament interactions. In
this case, the extracellular interactions are additionally
severed, since laminin 5 expression is reduced to half,
as indicated by reduced mRNA levels in keratinocytes
and by attenuated protein expression in the skin.
This family also reveals a novel aspect of skin biology.
The mother of the proband is a double heterozygote for
a null allele of both LAMB3 and of COL17A1. She
shows that 50% reduction of the expression level of both
gene products is tolerable and that it does not lead to
skin fragility, if the other components of the hemides-
mosome-anchoring complex are normal. So far, on the
basis of the knowledge that single heterozygotes for non-
sense mutations in JEB genes are unaffected, the hy-
pothesis has been that 50% reduction in one protein of
the complex does not attenuate epidermal adhesion. The
mother now demonstrates that more-extensive biologi-
cal safeguard measures exist for the protective functions
of the epidermis than was previously assumed. In this
context, the dental abnormalities of the mother and
other heterozygous mutation carriers are also interest-
ing. In the literature, enamel hypoplasia and pitting have
been described in two siblings with the heterozygous
COL17A1 mutation G627V (McGrath et al. 1996c), but
no reports exist on dental abnormalities in heterozygotes
with mutations in the genes encoding laminin 5, in spite
of the fact that laminin 5 is expressed in the ameloblast
basement membrane (Aberdam et al. 1994). Further dis-
section of the qualitative and quantitative role of the
individual anchoring-complex proteins in epidermal or
ameloblast adhesion obviously will not be possible in
humans; however, mouse models for null alleles of the
genes encoding these components—such as the laminin
b3 chain (Kuster et al. 1997), the a6 (Georges-Labouesse
et al. 1996) and b4 (van der Neut et al. 1996) integrins,
collagen VII (Ma¨nnikko¨ et al. 1999), or collagen
XVII—will be useful for such studies.
This report provides a protein-level rationale for di-
genic interactions of COL17A1 and LAMB3 and ex-
tends the spectrum of genetic heterogeneity in JEB. Fur-
thermore, it emphasizes that the identification of one
mutation in one gene is not sufficient for determination
of the genetic basis of JEB in a given family, a matter
that is of utmost importance for the genetic counseling
and prenatal diagnosis of affected individuals.
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